18F-FAPI versus 18F-FDG PET/CT in the Diagnosis of Relapsing Polychondritis
Xiaotong Guo1, Juan Chen1, Qian Zhao2
1Department of Pulmonary and Critical Care Medicine General Hospital of Ningxia Medical University Yinchuan Ningxia China.
Abstract:
Relapsing polychondritis (RP) is a rare immune-mediated systemic inflammatory disease with diverse clinical manifestations. Independent involvement of the respiratory system in RP is uncommon. In the event of respiratory involvement as the initial airway-only manifestation, the diagnosis of RP is challenging and might be delayed, and patients with respiratory involvement exhibit a poor prognosis. However, no specific diagnostic method is currently available for RP with respiratory system involvement as the main clinical manifestation. We present a 49-year-old female with the complaint of chronic dry cough accompanied by shortness of breath after exercise that has persisted for over a year. The patient was treated using corticosteroids. The patient's symptoms improved rapidly with the administration of 5 days of methylprednisolone sodium succinate at a dose of 40 mg/day. The treatment was then switched to methylprednisolone tablets at a dose of 40 mg/day, and the dosage was reduced by 4 mg every week until the cessation of therapy. Meanwhile, oral cyclophosphamide tablets were administered once every day at a dose of 100 mg each time. After 1 month of treatment, the symptoms of cough disappeared, the modified british medical research council (mMRC) grade dropped from 4 to 2, and the COPD assessment test (CAT) score dropped from 30 to 17. Repeated CT of the chest revealed that the tracheal wall thickening had alleviated. No recurrence was revealed in the follow-up visit 12 months after drug withdrawal. The patient underwent 18F-FDG PET/CT examination before hormone and immunosuppressive therapy, and 18F-FAPI PET/CT examination was performed 5 days later. The 18F-FDG PET/CT method revealed slight thickening of the local wall of the trachea and the left and right main bronchus, with no increase in the FDG metabolism, and no abnormalities in the rest of the cartilage. 18F-FAPI PET-CT imaging showed increased FAPI uptake in various parts of the body, including trachea and bronchus. The present study reports that compared to 18F-FDG PET/CT, the 18F-FAPI PET/CT revealed more lesions and provided a better image contrast, suggesting the latter as a suitable diagnostic method for RP, which could assist in improving the clinical management of RP patients.
Insights
Relapsing polychondritis (RP) can present with respiratory issues, making diagnosis difficult. 18F-FAPI PET/CT shows promise as a diagnostic tool for RP, potentially improving patient management.
Area of Science:
- Immunology
- Radiology
- Pulmonology
Background:
- Relapsing polychondritis (RP) is a rare immune-mediated disease.
- Respiratory involvement in RP is uncommon but associated with poor prognosis.
- Current diagnostic methods for RP with primary respiratory manifestation are lacking.
Purpose of the Study:
- To present a case of relapsing polychondritis with initial respiratory symptoms.
- To evaluate the utility of 18F-FAPI PET/CT in diagnosing RP with respiratory involvement.
- To highlight the potential of 18F-FAPI PET/CT in improving clinical management.
Main Methods:
- Case report of a 49-year-old female with chronic cough and dyspnea.
- Treatment with corticosteroids and cyclophosphamide.
- Diagnostic imaging including 18F-FDG PET/CT and 18F-FAPI PET/CT.
Main Results:
- The patient showed rapid symptom improvement with treatment.
- 18F-FDG PET/CT revealed mild tracheal and bronchial wall thickening without increased metabolism.
- 18F-FAPI PET/CT demonstrated increased FAPI uptake in the trachea and bronchi, offering better contrast and lesion detection compared to 18F-FDG PET/CT.
Conclusions:
- 18F-FAPI PET/CT may serve as a valuable diagnostic tool for relapsing polychondritis, especially when respiratory involvement is the primary manifestation.
- This imaging modality could aid in earlier and more accurate diagnosis, potentially leading to improved patient outcomes.
- Further research is warranted to validate 18F-FAPI PET/CT in a larger cohort of RP patients.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
